Biographie — Prof. Hussain Abdulrahman Al-Omar
Professor Hussain Al-Omar is a Consultant and Professor of Pharmacoeconomics and Pharmaceutical Policy at King Saud University. Professor Al-Omar received his Ph.D. from the Faculty of Life Sciences and Medicine at King’s College London, UK, and holds an executive education degree in business strategy and financial performance from the Institut Européend’Administration des Affaires (INSEAD), France. Complementing his formal degrees, Professor Al-Omar has undertaken advanced training in health technology assessment (HTA), health economics, HTA processes and methods for health technologies, and quantitative and qualitative research in health economics at leading UK institutions, including the University of Oxford, the University of York, and the National Institute for Health Research.
With over 26 years of experience, Professor Al-Omar is a recognized visionary strategic leader who has driven transformative advancements in health systems at national, regional, and global levels. Beyond his academic role, he has held several senior executive and advisory positions, including Executive Director of the Center for Health Technology Assessment and advisor to a number of HTA bodies and regulatory agencies.
Professor Al-Omar is a globally acknowledged expert in health strategy and policy, HTA, pricing and reimbursement, value-based healthcare and value-based contracting. His instrumental leadership has been pivotal in shaping numerous national, regional, and international health policies, strategic projects, and initiatives, all aimed at enhancing the sustainability and efficiency of health systems and services provision.
Professor Al-Omar brings a unique and distinct mix of strategic, scientific, operational and leadership expertise and is seen as a role model for many aspiring and established professionals in the field of HTA and Health Economics and Outcomes Research. His deep technical knowledge on HTA, pricing, reimbursement, and value-based contracting and procurementacross pharmaceuticals, medical devices, diagnostics, digital health, and artificial intelligence has made him second to none in this field in the entire region.